Phase 4 Study of Dolutegravir (DTG) in Russian Federation
Clinical trial NCT03314064 · COMPLETED
Trial details
- NCT number
- NCT03314064
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-08
- Primary completion
- 2018-10-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.